UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bisphosphonates and other bone agents for breast cancer

Cochrane database of systematic reviews, 2017-10, Vol.10 (11), p.CD003474

2017

Volltextzugriff (PDF)

The importance of patient-reported outcomes in clinical trials and strategies for future optimization

Patient related outcome measures, 2018-01, Vol.9, p.353-367

2018

Volltextzugriff (PDF)

Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer

Journal of clinical oncology, 2014-05, Vol.32 (13), p.1309-1316

2014

Volltextzugriff (PDF)

Physician-patient communication of costs and financial burden of cancer and its treatment: a systematic review of clinical guidelines

BMC cancer, 2021-09, Vol.21 (1), p.1-10, Article 1036

2021

Volltextzugriff (PDF)

Mindfulness-Based Cognitive Therapy in Advanced Prostate Cancer: A Randomized Controlled Trial

Journal of clinical oncology, 2017-01, Vol.35 (3), p.291-297

2017

Volltextzugriff (PDF)

Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review

BMJ open, 2016-06, Vol.6 (6), p.e010938-e010938

2016

Volltextzugriff (PDF)

Duration of Chemotherapy for Advanced Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Trials

Journal of clinical oncology, 2009-07, Vol.27 (20), p.3277-3283

2009

Volltextzugriff (PDF)

Bisphosphonates and other bone agents for breast cancer

Cochrane database of systematic reviews, 2012-02 (2), p.CD003474

2012

Volltextzugriff (PDF)

Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer

British journal of cancer, 2017-04, Vol.116 (8), p.1002-1011

2017

Volltextzugriff (PDF)

Sentinel-Lymph-Node-Based Management or Routine Axillary Clearance? Five-Year Outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 Trial: Assessment and Incidence of True Lymphedema

Annals of surgical oncology, 2017-04, Vol.24 (4), p.1064-1070

2017

Volltextzugriff (PDF)

Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer

Journal of clinical oncology, 2011-12, Vol.29 (34), p.4498-4504

2011

Volltextzugriff (PDF)

Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) – Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS)

Gynecologic oncology, 2018-01, Vol.148 (1), p.36-41

2018

Volltextzugriff (PDF)

The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study

Journal of cancer survivorship, 2016-04, Vol.10 (2), p.223-233

2016

Volltextzugriff (PDF)

Identification of Candidate Biomarkers of Therapeutic Response to Docetaxel by Proteomic Profiling

Cancer research (Chicago, Ill.), 2009-10, Vol.69 (19), p.7696-7703

2009

Volltextzugriff (PDF)

Patients’ preferences for chemotherapy in non-small-cell lung cancer: A systematic review

Lung cancer (Amsterdam, Netherlands), 2010-08, Vol.69 (2), p.141-147

2010

Volltextzugriff (PDF)

Certain Death in Uncertain Time: Informing Hope by Quantifying a Best Case Scenario

Journal of clinical oncology, 2010-06, Vol.28 (16), p.2802-2804

2010

Volltextzugriff (PDF)

Hope, Quality of Life, and Benefit From Treatment in Women Having Chemotherapy for Platinum‐Resistant/Refractory Recurrent Ovarian Cancer: The Gynecologic Cancer Intergroup Symptom Benefit Study

The oncologist (Dayton, Ohio), 2013-11, Vol.18 (11), p.1221-1228

2013

Volltextzugriff (PDF)

Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial

JNCI : Journal of the National Cancer Institute, 2010-08, Vol.102 (16), p.1253-1262

2010

Volltextzugriff (PDF)

Assessing Quality of Life During Chemotherapy for Pleural Mesothelioma: Feasibility, Validity, and Results of Using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module

Journal of clinical oncology, 2004-08, Vol.22 (15), p.3172-3180

2004

Volltextzugriff (PDF)

Adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The randomized phase III OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274)

Journal of clinical oncology, 2021-06, Vol.39 (18_suppl), p.LBA3-LBA3

2021

Volltextzugriff (PDF)

Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer

Psycho-oncology (Chichester, England), 2007-01, Vol.16 (1), p.48-59

2007

Volltextzugriff (PDF)

A phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: Outback (ANZGOG0902/GOG0274/RTOG1174)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.TPS5632-TPS5632

2014

Volltextzugriff (PDF)

A phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The OUTBACK TRIAL

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.TPS5116-TPS5116

2012

Volltextzugriff (PDF)

A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial

Annals of oncology, 2015-11, Vol.26 (11), p.2280-2286

2015

Volltextzugriff (PDF)

Sentinel-Lymph-Node-Based Management or Routine Axillary Clearance? One-Year Outcomes of Sentinel Node Biopsy Versus Axillary Clearance (SNAC): A Randomized Controlled Surgical Trial

Annals of surgical oncology, 2009-02, Vol.16 (2), p.266-275

Gill, Grantley

2009

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Humans
(19)
Oncology
(19)
Female
(11)
Middle Aged
(10)
Aged
(9)
Male
(9)
Quality Of Life
(9)
Tumors
(9)
Adult
(8)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Treatment Outcome
(7)
Chemotherapy
(6)
Aged, 80 And Over
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Breast Neoplasms - Pathology
(4)
Drug Administration Schedule
(4)
Follow-Up Studies
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bisphosphonates and other bone agents for breast cancer

The importance of patient-reported outcomes in clinical trials and strategies for future optimization

Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer

Physician-patient communication of costs and financial burden of cancer and its treatment: a systematic review of clinical guidelines

Mindfulness-Based Cognitive Therapy in Advanced Prostate Cancer: A Randomized Controlled Trial

Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review

Duration of Chemotherapy for Advanced Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Trials

Bisphosphonates and other bone agents for breast cancer

Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer

Sentinel-Lymph-Node-Based Management or Routine Axillary Clearance? Five-Year Outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 Trial: Assessment and Incidence of True Lymphedema

Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer

Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) – Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS)

The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study

Identification of Candidate Biomarkers of Therapeutic Response to Docetaxel by Proteomic Profiling

Patients’ preferences for chemotherapy in non-small-cell lung cancer: A systematic review

Certain Death in Uncertain Time: Informing Hope by Quantifying a Best Case Scenario

Hope, Quality of Life, and Benefit From Treatment in Women Having Chemotherapy for Platinum‐Resistant/Refractory Recurrent Ovarian Cancer: The Gynecologic Cancer Intergroup Symptom Benefit Study

Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial

Assessing Quality of Life During Chemotherapy for Pleural Mesothelioma: Feasibility, Validity, and Results of Using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module

Adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The randomized phase III OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274)

Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer

A phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: Outback (ANZGOG0902/GOG0274/RTOG1174)

A phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The OUTBACK TRIAL

A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial

Sentinel-Lymph-Node-Based Management or Routine Axillary Clearance? One-Year Outcomes of Sentinel Node Biopsy Versus Axillary Clearance (SNAC): A Randomized Controlled Surgical Trial

Aktive Filter

Suchergebnisse filtern